Abstract IA25: Third-generation inhibitors of mTOR
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.transcontrol16-ia25
Abstract: Precision medicines exert selective pressure on tumor cells that leads to the preferential growth of resistant subpopulations, necessitating the development of next-generation therapies to treat the evolving cancer. The PIK3CA–AKT–mTOR pathway is one of the… read more here.
Keywords: generation; generation inhibitors; mtor; third generation ... See more keywords